Serveur d'exploration sur les peptides biopesticides - Exploration (Accueil)

Index « KwdFr.i » - entrée « Adalimumab (MeSH) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Acétylmuramyl alanyl isoglutamine (usage thérapeutique) < Adalimumab (MeSH) < Adalimumab (administration et posologie)  Facettes :

List of bibliographic references indexed by Adalimumab (MeSH)

Number of relevant bibliographic references: 46.
[0-20] [0 - 20][0 - 46][20-40]
Ident.Authors (with country if any)Title
000581 (2019) Adrienn Er S [Hongrie] ; Nelli Farkas [Hongrie] ; Péter Hegyi [Hongrie] ; Anik Szab [Hongrie] ; Márta Balask [Hongrie] ; Gábor Veres [Hongrie] ; Lászl Czak [Hongrie] ; Judit Bajor [Hongrie] ; Hussain Alizadeh [Hongrie] ; Zoltán Rakonczay [Hongrie] ; Alexandra Mik [Hongrie] ; Tamás Habon [Hongrie] ; Bálint Er Ss [Hongrie] ; Bálint Bérczi [Hongrie] ; Patricia Sarl S [Hongrie]Anti-TNFα agents are the best choice in preventing postoperative Crohn's disease: A meta-analysis.
001371 (2015) Álcio Coutinho De Paula [Brésil] ; Marcos Pereira De Ávila [Brésil] ; David Leonardo Cruvinal Isaac [Brésil] ; Rodrigo Salustiano [Brésil] ; Aliny Pereira De Lima [Brésil] ; Francyelli Mariana Mello [Brésil] ; Flávia De Castro Pereira [Brésil] ; Pedro Henrique De Paula Silva [Brésil] ; Elisângela De Paula Silveira Lacerda [Brésil]Cytotoxicity and genotoxicity of intravitreal adalimumab administration in rabbit retinal cells.
001669 (2015) G. Cavalli [Italie] ; S. Franchini ; P. Aiello ; B. Guglielmi ; A. Berti ; C. Campochiaro ; M G Sabbadini ; E. Baldissera ; L. DagnaEfficacy and safety of biological agents in adult-onset Still's disease.
001767 (2015) Elizabeth V. Arkema [Suède] ; Jerker Jonsson [Suède] ; Eva Baecklund [Suède] ; Judith Bruchfeld [Suède] ; Nils Feltelius [Suède] ; Johan Askling [Suède]Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments?
001790 (2015) Divya Aggarwal [Royaume-Uni] ; Jimmy K. LimdiAnti-TNF therapy is associated with a reduction in radiation exposure in patients with Crohn's disease.
001824 (2014) Inmaculada De La Torre [Espagne] ; Lara Valor [Espagne] ; Juan Carlos Nieto [Espagne] ; María Montoro [Espagne] ; Luis Carre O [Espagne]Minimum effective dosages of anti-TNF in rheumatoid arthritis: a cross-sectional study.
001831 (2014) Noori Kim [États-Unis] ; Shimrat Notik ; Alice B. Gottlieb ; Pamela L. ScheinmanPatch test results in psoriasis patients on biologics.
001832 (2014) José Inciarte-Mundo [Espagne] ; M Victoria Hernández [Espagne] ; Violeta Rosario [Espagne] ; Virginia Ruiz-Esquide [Espagne] ; Sonia Cabrera-Villalba [Espagne] ; Julio Ramírez [Espagne] ; Juan D. Ca Ete [Espagne] ; Raimon Sanmartí [Espagne]Reduction of biological agent dose in rheumatic diseases: descriptive analysis of 153 patients in clinical practice conditions.
001858 (2014) Fabio Cacciapaglia [Italie] ; Francesca Buzzulini ; Luisa Arcarese ; Elisabetta Ferraro ; Antonella AfeltraThe use of an interferon-gamma release assay as a biomarker of response to anti-TNF-alpha treatment.
001965 (2014) Tamao Nakashita [Japon] ; Katsutoshi Ando [Japon] ; Norihiro Kaneko [Japon] ; Kazuhisa Takahashi [Japon] ; Shinji Motojima [Japon]Potential risk of TNF inhibitors on the progression of interstitial lung disease in patients with rheumatoid arthritis.
001A41 (2014) P. Gisondi [Italie] ; E. Pezzolo ; G. Lo Cascio ; G. GirolomoniLatent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy.
001B44 (2014) Marcin Włodarczyk [Pologne] ; Aleksandra Sobolewska [Pologne] ; Bartosz W Jcik [Pologne] ; Karolina Loga [Pologne] ; Jakub Fichna [Pologne] ; Maria Wi Niewska-Jarosi Ska [Pologne]Correlations between skin lesions induced by anti-tumor necrosis factor-α and selected cytokines in Crohn's disease patients.
001B55 (2014) P. Myrelid [Royaume-Uni] ; M. Marti-Gallostra ; S. Ashraf ; M L Sunde ; M. Tholin ; T. Oresland ; R E Lovegrove ; A. T Ttrup ; D W Kjaer ; B D GeorgeComplications in surgery for Crohn's disease after preoperative antitumour necrosis factor therapy.
001C27 (2014) Sandra Garcês [Portugal] ; Marília Antunes ; Elizabeth Benito-Garcia ; José Canas Da Silva ; Lucien Aarden ; Jocelyne DemengeotA preliminary algorithm introducing immunogenicity assessment in the management of patients with RA receiving tumour necrosis factor inhibitor therapies.
001C43 (2013) Esther Ramírez-Herráiz [Espagne] ; Vicente Escudero-Vilaplana ; Estefanía Ala N-Plaza ; Nicolás Trovato-L Pez ; Ana Herranz-Alonso ; Alberto Morell-Baladr N ; María Sanjurjo-SáezEfficiency of adalimumab, etanercept and infliximab in rheumatoid arthritis patients: dosing patterns and effectiveness in daily clinical practice.
001C47 (2013) Pilar Espi O-Lorenzo [Espagne] ; Sara Manrique-Arija ; Inmaculada Ure A ; Francisco Gabriel Jiménez-Nú Ez ; María L Pez-Lasanta ; Carmen María Romero-Barco ; María Angeles Belmonte-L Pez ; María Victoria Irigoyen ; Antonio Fernández-NebroBaseline comorbidities in patients with rheumatoid arthritis who have been prescribed biological therapy: a case control study.
001C65 (2013) Kevin E. Kip [États-Unis] ; Jason M. Swoger ; Lisa M. Grandinetti ; Arthur M. Barrie ; Julia B. Greer ; Miguel D. RegueiroTumor necrosis factor α antagonist-associated psoriasis in inflammatory diseases: an analysis of the FDA adverse event reporting system.
001C67 (2013) Marina Amaral De Vila Machado [Brésil] ; Mariana Michel Barbosa ; Alessandra Maciel Almeida ; Vânia Eloisa De Araújo ; Adriana Maria Kakehasi ; Eli Iola Gurgel Andrade ; Mariangela Leal Cherchiglia ; Francisco De Assis AcurcioTreatment of ankylosing spondylitis with TNF blockers: a meta-analysis.
001D33 (2013) Matti Waterman [Canada] ; Wei Xu ; Amreen Dinani ; A Hillary Steinhart ; Kenneth Croitoru ; Geoffrey C. Nguyen ; Robin S. Mcleod ; Gordon R. Greenberg ; Zane Cohen ; Mark S. SilverbergPreoperative biological therapy and short-term outcomes of abdominal surgery in patients with inflammatory bowel disease.
001E58 (2013) Evren Odyakmaz Demirsoy ; Rebiay K Ran ; Selma Salman ; Ci Dem Ca Layan ; Aysun Sikar Aktürk ; Dilek Bayramgurler ; Nilgün BilenEffectiveness of systemic treatment agents on psoriatic nails: a comparative study.
001F53 (2012) Lucio Ventura-Ríos [Mexique] ; David Ba Uelos-Ramírez ; María Del Carmen Hernández-Quiroz ; Manuel Robles-San Román ; Fedra Irazoque-Palazuelos ; María Victoria Goycochea-RoblesPatient survival and safety with biologic therapy. Results of the Mexican National Registry Biobadamex 1.0.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Bois/explor/BiopestPeptidV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Adalimumab (MeSH)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Adalimumab (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Bois
   |area=    BiopestPeptidV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Adalimumab (MeSH)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Thu Nov 19 19:22:35 2020. Site generation: Thu Nov 19 19:33:26 2020